{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:21:09Z","timestamp":1792513269106,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005690","name":"Universit\u00e4t des Saarlandes","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005690","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Cilostazol has previously been shown to reduce liver steatosis and enhance hepatic perfusion. We investigated the effects of cilostazol after major hepatectomy in a steatotic rat model. Six weeks prior to surgery, Sprague\u2013Dawley rats were fed with a high-fructose diet. The treatment group received daily 5\u00a0mg\/kg cilostazol. Seven days following the cilostazol treatment, all animals underwent 70% liver resection (PHX). Analysis of hepatic blood flow and microcirculation and immunohistochemical examinations were conducted 30\u00a0min after PHX (postoperative day [POD] 0) as well as on POD 1, POD 3 and POD 7. The weight of cilostazol-treated animals was significantly reduced compared to untreated controls after completion of the 6-week high-FRC diet. Furthermore, 41% macrovesicular steatosis was found in the control group compared to 8% in the cilostazol group. Hepatic arterial and portal venous perfusion were increased in the cilostazol group on POD 7. Lower liver enzyme release was found postoperatively in cilostazol-treated animals. Moreover, apoptosis and neutrophil infiltration were reduced after cilostazol treatment. Proliferation of hepatocytes and liver regeneration after PHX were significantly increased in the cilostazol group. Consequently, cilostazol should be evaluated as a novel strategy to reduce the rate of liver failure after PHX in steatotic liver.<\/jats:p>","DOI":"10.1038\/s41598-025-87135-z","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T04:03:09Z","timestamp":1737518589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Perioperative treatment with cilostazol reverses steatosis and improves liver regeneration after major hepatectomy in a steatotic rat model"],"prefix":"10.1038","volume":"15","author":[{"given":"Sebastian","family":"Holl\u00e4nder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"von Heesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gereon","family":"G\u00e4belein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias W.","family":"Laschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Menger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Glanemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios E.","family":"Spiliotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"87135_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001235","author":"D Tomic","year":"2018","unstructured":"Tomic, D., Kemp, W. W. & Roberts, S. K. Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies. Eur. J. Gastroenterol. Hepatol. https:\/\/doi.org\/10.1097\/MEG.0000000000001235 (2018).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"87135_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","volume":"9","author":"M Benedict","year":"2017","unstructured":"Benedict, M. & Zhang, X. Non-alcoholic fatty liver disease: An expanded review. World J. Hepatol. 9, 715\u2013732. https:\/\/doi.org\/10.4254\/wjh.v9.i16.715 (2017).","journal-title":"World J. Hepatol."},{"key":"87135_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17050774","author":"L Calzadilla Bertot","year":"2016","unstructured":"Calzadilla Bertot, L. & Adams, L. A. The natural course of non-alcoholic fatty liver disease. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms17050774 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"87135_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11\u201320. https:\/\/doi.org\/10.1038\/nrgastro.2017.109 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"87135_CR5","doi-asserted-by":"publisher","DOI":"10.1080\/08941939.2017.1334844","author":"N Sikalias","year":"2017","unstructured":"Sikalias, N. et al. Intermittent ischemic preconditioning protects against hepatic ischemia-reperfusion injury and extensive hepatectomy in steatotic rat liver. J. Invest. Surg. https:\/\/doi.org\/10.1080\/08941939.2017.1334844 (2017).","journal-title":"J. Invest. Surg."},{"key":"87135_CR6","doi-asserted-by":"publisher","first-page":"8364","DOI":"10.3748\/wjg.v20.i26.8364","volume":"20","author":"O Kucera","year":"2014","unstructured":"Kucera, O. & Cervinkova, Z. Experimental models of non-alcoholic fatty liver disease in rats. World J. Gastroenterol. 20, 8364\u20138376. https:\/\/doi.org\/10.3748\/wjg.v20.i26.8364 (2014).","journal-title":"World J. Gastroenterol."},{"key":"87135_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","volume":"34","author":"G Vernon","year":"2011","unstructured":"Vernon, G., Baranova, A. & Younossi, Z. M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment. Pharmacol. Ther. 34, 274\u2013285. https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04724.x (2011).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"87135_CR8","doi-asserted-by":"publisher","first-page":"100192","DOI":"10.1016\/j.jhepr.2020.100192","volume":"2","author":"P Burra","year":"2020","unstructured":"Burra, P., Becchetti, C. & Germani, G. NAFLD and liver transplantation: Disease burden, current management and future challenges. JHEP Rep. 2, 100192. https:\/\/doi.org\/10.1016\/j.jhepr.2020.100192 (2020).","journal-title":"JHEP Rep."},{"key":"87135_CR9","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/bjs.7194","volume":"97","author":"VE de Meijer","year":"2010","unstructured":"de Meijer, V. E., Kalish, B. T., Puder, M. & Ijzermans, J. N. Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br. J. Surg. 97, 1331\u20131339. https:\/\/doi.org\/10.1002\/bjs.7194 (2010).","journal-title":"Br. J. Surg."},{"key":"87135_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12916-022-02239-x","volume":"20","author":"A Murtha-Lemekhova","year":"2022","unstructured":"Murtha-Lemekhova, A. et al. Is metabolic syndrome a risk factor in hepatectomy? A meta-analysis with subgroup analysis for histologically confirmed hepatic manifestations. BMC Med. 20, 47. https:\/\/doi.org\/10.1186\/s12916-022-02239-x (2022).","journal-title":"BMC Med."},{"key":"87135_CR11","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1007\/s00268-021-06230-0","volume":"45","author":"D Villagomez","year":"2021","unstructured":"Villagomez, D. et al. Hepatic steatosis is associated with an increased risk of postoperative infections and perioperative transfusion requirements in patients undergoing hepatectomy. World J. Surg. 45, 3654\u20133659. https:\/\/doi.org\/10.1007\/s00268-021-06230-0 (2021).","journal-title":"World J. Surg."},{"key":"87135_CR12","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/gut.2007.144550","volume":"57","author":"K Fujita","year":"2008","unstructured":"Fujita, K. et al. Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease. Gut 57, 1583\u20131591. https:\/\/doi.org\/10.1136\/gut.2007.144550 (2008).","journal-title":"Gut"},{"key":"87135_CR13","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/lt.24114","volume":"21","author":"M von Heesen","year":"2015","unstructured":"von Heesen, M. et al. Cilostazol improves hepatic blood perfusion, microcirculation, and liver regeneration after major hepatectomy in rats. Liver Transpl. 21, 792\u2013800. https:\/\/doi.org\/10.1002\/lt.24114 (2015).","journal-title":"Liver Transpl."},{"key":"87135_CR14","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1016\/j.jss.2011.01.036","volume":"168","author":"M von Heesen","year":"2011","unstructured":"von Heesen, M. et al. Split-liver procedure and inflammatory response: improvement by pharmacological preconditioning. J. Surg. Res. 168, e125-135. https:\/\/doi.org\/10.1016\/j.jss.2011.01.036 (2011).","journal-title":"J. Surg. Res."},{"key":"87135_CR15","unstructured":"Guide for the Care and Use of Laboratory Animals The National Academies Collection: Reports funded by National Institutes of Health (ed th) (2011)."},{"key":"87135_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000411","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol. https:\/\/doi.org\/10.1371\/journal.pbio.3000411 (2020).","journal-title":"PLoS Biol."},{"key":"87135_CR17","first-page":"186","volume":"12","author":"GM Higgins","year":"1931","unstructured":"Higgins, G. M. Experimental pathology of the liver. I. Restauration of the liver of the white rat following partial surgical removal. Arch. Pathol. 12, 186\u2013202 (1931).","journal-title":"Arch. Pathol."},{"key":"87135_CR18","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/bjs.7003","volume":"97","author":"O Kollmar","year":"2010","unstructured":"Kollmar, O. et al. Tumour growth following portal branch ligation in an experimental model of liver metastases. Br. J. Surg. 97, 917\u2013926. https:\/\/doi.org\/10.1002\/bjs.7003 (2010).","journal-title":"Br. J. Surg."},{"key":"87135_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/2047-783X-18-54","volume":"18","author":"R Kumamoto","year":"2013","unstructured":"Kumamoto, R. et al. Dietary fructose enhances the incidence of precancerous hepatocytes induced by administration of diethylnitrosamine in rat. Eur. J. Med. Res. 18, 54. https:\/\/doi.org\/10.1186\/2047-783X-18-54 (2013).","journal-title":"Eur. J. Med. Res."},{"key":"87135_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10517-006-0146-8","volume":"141","author":"LK Khnychenko","year":"2006","unstructured":"Khnychenko, L. K., Stepanov, I. I. & Sapronov, N. S. Regression analysis of relationship between liver weight and body weight after partial hepatectomy in rats. Bull. Exp. Biol. Med. 141, 269\u2013271. https:\/\/doi.org\/10.1007\/s10517-006-0146-8 (2006).","journal-title":"Bull. Exp. Biol. Med."},{"key":"87135_CR21","doi-asserted-by":"publisher","first-page":"9085801","DOI":"10.1155\/2020\/9085801","volume":"2020","author":"WC Li","year":"2020","unstructured":"Li, W. C. et al. Yiqi Huoxue recipe improves liver regeneration in rats after partial hepatectomy via JNK pathway. Evid. Based Complement. Alternat. Med. 2020, 9085801. https:\/\/doi.org\/10.1155\/2020\/9085801 (2020).","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"87135_CR22","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1593\/neo.07559","volume":"9","author":"O Kollmar","year":"2007","unstructured":"Kollmar, O. et al. Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis. Neoplasia 9, 862\u2013870. https:\/\/doi.org\/10.1593\/neo.07559 (2007).","journal-title":"Neoplasia"},{"key":"87135_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10585-011-9432-6","volume":"29","author":"J Sperling","year":"2012","unstructured":"Sperling, J. et al. Hepatic arterial infusion of bevacizumab in combination with oxaliplatin reduces tumor growth in a rat model of colorectal liver metastases. Clin. Exp. Metastasis 29, 91\u201399. https:\/\/doi.org\/10.1007\/s10585-011-9432-6 (2012).","journal-title":"Clin. Exp. Metastasis"},{"key":"87135_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.tem.2010.10.003","volume":"22","author":"VT Samuel","year":"2011","unstructured":"Samuel, V. T. Fructose induced lipogenesis: from sugar to fat to insulin resistance. Trends Endocrinol. Metab. 22, 60\u201365. https:\/\/doi.org\/10.1016\/j.tem.2010.10.003 (2011).","journal-title":"Trends Endocrinol. Metab."},{"key":"87135_CR25","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.hpb.2021.01.009","volume":"23","author":"KM Chin","year":"2021","unstructured":"Chin, K. M. et al. Outcomes after curative therapy for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: a meta-analysis and review of current literature. HPB (Oxford) 23, 1164\u20131174. https:\/\/doi.org\/10.1016\/j.hpb.2021.01.009 (2021).","journal-title":"HPB (Oxford)"},{"key":"87135_CR26","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/SLA.0000000000001968","volume":"266","author":"M Linecker","year":"2017","unstructured":"Linecker, M. et al. Omega-3 fatty acids protect fatty and lean mouse livers after major hepatectomy. Ann. Surg. 266, 324\u2013332. https:\/\/doi.org\/10.1097\/SLA.0000000000001968 (2017).","journal-title":"Ann. Surg."},{"key":"87135_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3109\/08941939.2014.971206","volume":"28","author":"S Hoppe","year":"2015","unstructured":"Hoppe, S. et al. Nonalcoholic steatohepatits and liver steatosis modify partial hepatectomy recovery. J. Invest. Surg. 28, 24\u201331. https:\/\/doi.org\/10.3109\/08941939.2014.971206 (2015).","journal-title":"J. Invest. Surg."},{"key":"87135_CR28","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s10620-018-5346-3","volume":"64","author":"J Zhao","year":"2019","unstructured":"Zhao, J. et al. NAFLD induction delays postoperative liver regeneration of ALPPS in rats. Dig. Dis. Sci. 64, 456\u2013468. https:\/\/doi.org\/10.1007\/s10620-018-5346-3 (2019).","journal-title":"Dig. Dis. Sci."},{"key":"87135_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bbrc.2011.02.131","volume":"407","author":"S Tanoue","year":"2011","unstructured":"Tanoue, S. et al. Liver regeneration after partial hepatectomy in rat is more impaired in a steatotic liver induced by dietary fructose compared to dietary fat. Biochem. Biophys. Res. Commun. 407, 163\u2013168. https:\/\/doi.org\/10.1016\/j.bbrc.2011.02.131 (2011).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"87135_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116280","author":"T Min","year":"2024","unstructured":"Min, T. et al. Cilostazol attenuates hepatic steatosis and intestinal disorders in nonalcoholic fatty liver disease. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms25116280 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"87135_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081852","author":"DH Seo","year":"2022","unstructured":"Seo, D. H. et al. Effects of a phosphodiesterase inhibitor on the browning of adipose tissue in mice. Biomedicines https:\/\/doi.org\/10.3390\/biomedicines10081852 (2022).","journal-title":"Biomedicines"},{"key":"87135_CR32","first-page":"1144","volume":"35","author":"Y Kimura","year":"1985","unstructured":"Kimura, Y., Tani, T., Kanbe, T. & Watanabe, K. Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneimittelforschung 35, 1144\u20131149 (1985).","journal-title":"Arzneimittelforschung"},{"key":"87135_CR33","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/lt.23884","volume":"20","author":"K Iguchi","year":"2014","unstructured":"Iguchi, K. et al. Hepatoprotective effect by pretreatment with olprinone in a swine partial hepatectomy model. Liver Transpl. 20, 838\u2013849. https:\/\/doi.org\/10.1002\/lt.23884 (2014).","journal-title":"Liver Transpl."},{"issue":"Suppl 1","key":"87135_CR34","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1111\/j.1440-1746.2006.04645.x","volume":"22","author":"E Hatano","year":"2007","unstructured":"Hatano, E. Tumor necrosis factor signaling in hepatocyte apoptosis. J. Gastroenterol. Hepatol. 22(Suppl 1), S43-44. https:\/\/doi.org\/10.1111\/j.1440-1746.2006.04645.x (2007).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"87135_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000101009","volume":"39","author":"M Schmeding","year":"2007","unstructured":"Schmeding, M., Neumann, U. P., Boas-Knoop, S., Spinelli, A. & Neuhaus, P. Erythropoietin reduces ischemia-reperfusion injury in the rat liver. Eur. Surg. Res. 39, 189\u2013197. https:\/\/doi.org\/10.1159\/000101009 (2007).","journal-title":"Eur. Surg. Res."},{"key":"87135_CR36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ejphar.2018.01.021","volume":"822","author":"SA El Awdan","year":"2018","unstructured":"El Awdan, S. A., Amin, M. M. & Hassan, A. Cilostazol attenuates indices of liver damage induced by thioacetamide in albino rats through regulating inflammatory cytokines and apoptotic biomarkers. Eur. J. Pharmacol. 822, 168\u2013176. https:\/\/doi.org\/10.1016\/j.ejphar.2018.01.021 (2018).","journal-title":"Eur. J. Pharmacol."},{"key":"87135_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5551\/jat.e492","volume":"14","author":"D Mori","year":"2007","unstructured":"Mori, D. et al. Cilostazol inhibits monocytic cell adhesion to vascular endothelium via upregulation of cAMP. J. Atheroscler. Thromb. 14, 213\u2013218. https:\/\/doi.org\/10.5551\/jat.e492 (2007).","journal-title":"J. Atheroscler. Thromb."},{"key":"87135_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jss.2005.07.020","volume":"130","author":"A Akcan","year":"2006","unstructured":"Akcan, A. et al. The effect of amrinone on liver regeneration in experimental hepatic resection model. J. Surg. Res. 130, 66\u201372. https:\/\/doi.org\/10.1016\/j.jss.2005.07.020 (2006).","journal-title":"J. Surg. Res."},{"key":"87135_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/lt.22189","volume":"17","author":"K Yamanaka","year":"2011","unstructured":"Yamanaka, K. et al. Olprinone attenuates excessive shear stress through up-regulation of endothelial nitric oxide synthase in a rat excessive hepatectomy model. Liver Transpl. 17, 60\u201369. https:\/\/doi.org\/10.1002\/lt.22189 (2011).","journal-title":"Liver Transpl."},{"key":"87135_CR40","doi-asserted-by":"publisher","first-page":"E440","DOI":"10.1152\/ajpendo.00032.2017","volume":"313","author":"TA Zimmers","year":"2017","unstructured":"Zimmers, T. A., Jin, X., Zhang, Z., Jiang, Y. & Koniaris, L. G. Epidermal growth factor receptor restoration rescues the fatty liver regeneration in mice. Am. J. Physiol. Endocrinol. Metab. 313, E440\u2013E449. https:\/\/doi.org\/10.1152\/ajpendo.00032.2017 (2017).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"87135_CR41","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s10585-014-9669-y","volume":"31","author":"MJ Strowitzki","year":"2014","unstructured":"Strowitzki, M. J. et al. The phosphodiesterase 3 inhibitor cilostazol does not stimulate growth of colorectal liver metastases after major hepatectomy. Clin. Exp. Metastasis 31, 795\u2013803. https:\/\/doi.org\/10.1007\/s10585-014-9669-y (2014).","journal-title":"Clin. Exp. Metastasis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87135-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87135-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87135-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T15:49:24Z","timestamp":1737560964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87135-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["87135"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-87135-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]},"assertion":[{"value":"4 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2753"}}